Results 1 to 10 of about 49 (46)
[Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding]. [PDF]
Z Rheumatol, 2021 Häfeli C, Förger F.
europepmc +1 more source
2-Butoxyethylacetat: MAK-Begründung, Nachtrag. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission.
europepmc +1 more source
Schwangerschaftsgruppen, neue Gruppe B (Verdacht): MAK-Begründung. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission.
europepmc +1 more source
N-Methylanilin: MAK-Begründung, Nachtrag. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission.
europepmc +1 more source
2-Butoxyethanol: MAK-Begründung, Nachtrag. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission.
europepmc +1 more source
Xylidin, Isomere (2,3-Xylidin, 2,5-Xylidin, 3,4-Xylidin, 3,5-Xylidin): MAK-Begründung, Nachtrag. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission.
europepmc +1 more source
2-Methoxyethanol: MAK-Begründung, Nachtrag. [PDF]
MAK Collect Occup Health SafHartwig A +1 more
europepmc +1 more source
Trimethylbenzol (alle Isomere): MAK-Begründung, Nachtrag. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission.
europepmc +1 more source
5-Ethyl-3,7-dioxa-1-azabicyclo[3.3.0]octan (EDAO): MAK-Begründung, Nachtrag. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission .
europepmc +1 more source
Benzophenon-3: MAK-Begründung. [PDF]
MAK Collect Occup Health SafHartwig A, MAK Commission.
europepmc +1 more source